CRISPR Therapeutics (CRSP)
(Real Time Quote from BATS)
$57.58 USD
-0.29 (-0.50%)
Updated Jun 10, 2024 09:32 AM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.37 | 0.00% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of -$1.43 per share, beating the Zacks Consensus Estimate of $-1.63 per share. This reflects a positive earnings surprise of 12.27%. Look out for CRSP's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.37 per share, reflecting a year-over-year decrease of 39.8%.
Earnings History
Price & Consensus
Zacks News for CRSP
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services